Skip to main content

Table 2 Patient demographics and baseline characteristics

From: Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)

Characteristic

Full analysis set (n = 2703)

Age (years)

 < 40

46 (1.7)

 40–54

470 (17.4)

 55–69

1529 (56.6)

 ≥ 70

658 (24.3)

 Mean ± SD

62.7 ± 10.0

Sex

 Men

1436 (53.1)

 Women

1267 (46.9)

Race

 Caucasian

2693 (99.6)

 Asian

9 (0.3)

 African

1 (0.0)

BMI (kg/m2)

 < 25

441 (16.3)

 25–29

1133 (41.9)

 ≥ 30

1129 (41.8)

 Mean ± SD

29.5 ± 4.8

Waist circumference (cm)

97.0 ± 12.7

Systolic blood pressure (mmHg)

135.1 ± 16.0

Diastolic blood pressure (mmHg)

82.3 ± 9.5

Total cholesterol (mmol/l)

4.69 ± 1.19

LDL-C (mmol/l)

2.76 ± 1.02

HDL-C (mmol/l)

1.24 ± 0.32

Glucose (mmol/l)

6.16 ± 2.13

Creatinine (µmol/l)

81.29 ± 22.06

HbA1c (%)

5.84 ± 0.97

HbA1c (mmol/mol)a

40 ± 11

Hemoglobin (g/dl)

14.19 ± 1.35

Hematocrit (%)

42.17 ± 3.62

eGFR (ml/min/1.73 m2)b

 < 30

14 (0.5)

 30–59

309 (11.4)

 ≥ 60

2380 (88.1)

CV risk factors

 Arterial hypertension

2511 (92.9)

 Family history of premature CHD

963 (35.6)

 Previously diagnosed diabetes mellitus

650 (24.0)

 Tobacco smoker

491 (18.2)

CVD history

 ≥ 1 diagnosis

2254 (83.4)

 Myocardial infarction

1122 (41.5)

 Angina

1306 (48.3)

 Unstable angina

428 (15.8)

 Revascularization

1047 (38.7)

 Peripheral arterial disease

736 (27.2)

 Ischemic stroke

222 (8.2)

 Stroke of unknown etiology

46 (1.7)

Other significant concomitant diseases

 Microalbuminuria

248 (9.2)

 Macroalbuminuria

50 (1.8)

 Diabetic retinopathy

222 (8.2)

 Diabetic neuropathy

221 (8.2)

CV risk categoryb

 Low

2 (0.1)

 Moderate

86 (3.2)

 High

151 (5.6)

 Very high

2464 (91.2)

  1. Numbers are n (%) or mean ± SD. Data were available for all 2703 patients in the full analysis set, except for waist circumference (n = 2702) and levels of glucose (n = 2687), HbA1c (n = 2594), hemoglobin, and hematocrit (both n = 2579)
  2. BMI body mass index, CHD coronary heart disease, CV cardiovascular, CVD cardiovascular disease, eGFR estimated glomerular filtration rate, HbA1c glycosylated hemoglobin, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, SD standard deviation
  3. aCalculated, not measured
  4. bCalculated using central laboratory data